Andrew Wolf, MD

Recognitions

• Medical Student Teaching Award, University of Colorado Department of Neurology (2025)
• Al Anderson Teaching Award, University of Colorado Neurology Residency Program (2024)

Research Interests

Multiple sclerosis, NMOSD, MOGAD, and neurosarcoidosis clinical trials, novel cellular therapies for neuroimmunological conditions, neurological complications of immunotherapies, infectious complications of disease-modifying therapies, neurological complications of stem cell therapies, acute management of neuroinflammatory diseases.

Publications

• Ardakani RV, Crane PD, Pastula DM, Chauhan L, Matthews E, Money KM, Shah A, Piquet AL, Gross RH, Carlson AM, Tyler KL, Corboy JR, Alvarez E, Wolf AB. West Nile Virus Neuroinvasive Disease in Patients Treated With Anti-CD20 Therapies. Neurol Clin Pract. 2025 Aug;15(4):e200489. PubMed PMID: 40584641
• Ribeiro AS, Wolf AB, Leschek EW, Schonberger LB, Abrams JY, Maddox RA, Appleby BS, Glisic K, Carlson A, Matthews E. Cadaveric Human Growth Hormone-Associated Creutzfeldt-Jakob Disease with Long Latency Period, United States. Emerg Infect Dis. 2025 Jun;31(6):1189-1192. PubMed PMID: 40439459
• Carlson AM, Sollero CEV, Wolf AB, Sillau S, Schmitt BL, Money KM, Nair KV, Piquet AL, Bennett JL. The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population. Ann Clin Transl Neurol. 2025 Jan;12(1):169-179. PubMed PMID: 39708292
• Riberio A, Wolf AB, Lescheck EW, Schonberger LW, Abrams JY, Maddox RA, Appleby BS, Glisic K, Carlson AM, Matthews E. Cadaveric human growth hormone-associated Creutzfeldt-Jakob disease a very long latency period. Emerg Inf Dis. In press.
• Ardakani RV*, Crane PD*, Pastula DM, Chauhan L, Matthews E, Money KM, Shah A, Piquet AL, Gross RH, Carlson AM, Tyler KL, Corboy JR, Alvarez E, Wolf AB. West Nile virus neuroinvasive disease in patients treated with anti-CD20 therapies. Neurol Clin Pract. DOI 10.1212/CPJ.0000000000200489. *Contributed Equally
• Carlson AM*, Sollero CEV*, Wolf AB, Sillau S, Schmitt B, Money KM, Nari KV, Piquet AL, Bennett JL (2024). The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population. Ann Clin Transl Neurol, 12: 169-179. DOI 10.1002/acn3.52268. *Contributed Equally
• Wolf AB & Shah AA (2024). Clinical trials in multiple sclerosis. MedLink Neurology.
• Wolf AB, Alvarez E, Corboy JR. Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience. JAMA Neurol. 2024 Jan 1;81(1):87. PubMed PMID: 37983039
• Quinn CM, Rajarajan P, Gill AJ, Kopinsky H, Wolf AB, de Camargo CS, Lamb J, Bacon TE, Murray JC, Probasco JC, Galetta KM, Kantor D, Coyle P, Bhise V, Alvarez E, Conway SE, Bhattacharyya S, Kister I. Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications. Neurology. 2024 Dec 10;103(11):e210003. PubMed PMID: 39541548
• Wolf AB, Corboy JR. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Neurol Clin Pract. 2024 Oct;14(5):e200330. PubMed PMID: 38919933
• Wolf AB, Money KM, Chandnani A, Daley CL, Griffith DE, Chauhan L, Coffman N, Piquet AL, Tyler KL, Zimmer SM, Montague BT, Mann S, Pastula DM. Mycobacterium abscessus Meningitis Associated with Stem Cell Treatment During Medical Tourism. Emerg Infect Dis. 2023 Aug;29(8):1655-1658. PubMed PMID: 37486227
• Wolf AB, Palace J, Bennett JL. Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD). 2023. Curr Treat Options Neurol. In press.
• Wolf AB & Alvarez E. Ublituximab: A novel anti-CD20 therapy for multiple sclerosis. touchREVIEWS in Neurology. 2022. DOI: 10.17925/USN.2022.18.2.117
• Shah AA, Wolf AB, Declusin A, Coleman K, Kammeyer R, Khan B, Corboy JR. Challenging Cases in Neuroimmunology. Semin Neurol. 2022 Dec;42(6):695-707. PubMed PMID: 36690027
• Shiao JC, Wolf AB, Rabinovitch RA, Smith C, Kleinschmidt-DeMasters BK, Ney DE. Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy. Adv Radiat Oncol. 2022 Mar-Apr;7(2):100831. PubMed PMID: 34934868
• Vollmer BL, Wolf AB, Sillau S, Corboy JR, Alvarez E. Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis. Front Neurol. 2021;12:799138. PubMed PMID: 35145470
• Wolf A, Alvarez E. COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying Therapy. Neurol Clin Pract. 2021 Aug;11(4):358-361. PubMed PMID: 34484934
• Wolf AB & Felsen G. How public health policy can be informed by neuroscience. Behav Public Policy. 2019; 3: 37-46. DOI 10.1017/bpp.2017.9.
• Wolf AB, Ryerson LZ, Pandey K, McGettigan BM, Vollmer T, Corboy JR, Alvarez E. Rituximab-induced serum sickness in multiple sclerosis patients. Mult Scler Relat Disord. 2019 Nov;36:101402. PubMed PMID: 31542710
• Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA. Visual system manifestations of Alzheimer's disease. Acta Ophthalmol. 2017 Dec;95(8):e668-e676. PubMed PMID: 27864881
• Perkins M, Wolf AB, Chavira B, Shonebarger D, Meckel JP, Leung L, Ballina L, Ly S, Saini A, Jones TB, Vallejo J, Jentarra G, Valla J. Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ?4 Carriers. J Alzheimers Dis. 2016 Apr 23;53(1):95-106. PubMed PMID: 27128370
• Wolf AB, Lintz MJ, Costabile JD, Thompson JA, Stubblefield EA, Felsen G. An integrative role for the superior colliculus in selecting targets for movements. J Neurophysiol. 2015 Oct;114(4):2118-31. PubMed PMID: 26203103
• Snyder LA, Wolf AB, Oppenlander ME, Bina R, Wilson JR, Ashby L, Brachman D, Coons SW, Spetzler RF, Sanai N. The impact of extent of resection on malignant transformation of pure oligodendrogliomas. J Neurosurg. 2014 Feb;120(2):309-14. PubMed PMID: 24313617
• Oppenlander ME, Wolf AB, Snyder LA, Bina R, Wilson JR, Coons SW, Ashby LS, Brachman D, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity. J Neurosurg. 2014 Apr;120(4):846-53. PubMed PMID: 24484232
• Hardesty DA, Wolf AB, Brachman DG, McBride HL, Youssef E, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg. 2013 Aug;119(2):475-81. PubMed PMID: 23394332
• Wolf AB, Caselli RJ, Reiman EM, Valla J. APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease. Neurobiol Aging. 2013 Apr;34(4):1007-17. PubMed PMID: 23159550
• Wolf AB, Valla J, Bu G, Kim J, LaDu MJ, Reiman EM, Caselli RJ. Apolipoprotein E as a ß-amyloid-independent factor in Alzheimer's disease. Alzheimers Res Ther. 2013;5(5):38. PubMed PMID: 23998393
• Wolf AB, Braden BB, Bimonte-Nelson H, Kusne Y, Young N, Engler-Chiurazzi E, Garcia AN, Walker DG, Moses GS, Tran H, LaFerla F, Lue L, Emerson Lombardo N, Valla J. Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention. J Alzheimers Dis. 2012;32(1):217-32. PubMed PMID: 22796872
• Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE e4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis. 2010;22(1):307-13. PubMed PMID: 20847408
• Azargui S, Xia JL, McClain IJ, Dacey M, Wolf AB, Palestine AG, Reddy AK. Multiple sclerosis associated uveitis successfully controlled with ofatumumab. J Ophthalmic Inflamm Infect. In press.

Professional Memberships

• American Neurological Association, Member
• American Academy of Neurology, Member
• Colorado Neurological Society, Member
• Autoimmune Encephalitis Alliance, Member
• Autoimmune Neurology Research Consortium, Board Member
• Siegel Rare Neuroimmune Association, Member
• Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Member
• Consortium of Multiple Sclerosis Centers, Member

Practice Locations

UCHealth Neurosciences Center - Anschutz Medical Campus
1635 Aurora Ct
4th Floor
Aurora, CO 80045
720-848-2080

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000

Hospital Affiliation

• University of Colorado Hospital
• Denver Health Medical Center

Center Affiliations

• Rocky Mountain Multiple Sclerosis Center

Specialty Information

Specialties

• Neurology, Board Certification (2022)
• Neuroimmunology